Translated using Google Translate from the original French. Unfortunately not a great start to using drug therapies for COVID 19.
Monday, March 30, 11:35 p.m .: Medicines agency warns of side effects of experimental therapies
France's drug agency ANSM has identified potential dangerous side effects, including deaths, in new treatments for lung disease Covid-19. ANSM director Dominique Martin said that around 30 different undesirable serious side effects had occurred in patients infected with the novel coronavirus and treated with plaquenil or other medications such as Kaletra. There were also three deaths.
Plaquenil contains the active ingredient hydroxychloroquine, which is used in malaria prophylaxis. Kaletra contains a combination of the active substances lopinavir and ritonavir, which are commonly used to treat HIV patients. The side effects have been reported from hospitals. Martin still has to investigate whether they can be attributed to the experimental methods mentioned for the treatment of the lung disease Covid-19. Hopefully the first results will be available by the end of the week. In any case, he warned not to take such medication "under any circumstances"